Table 2

Comparison of clinical features of vitiligo patients with and without anti-thyroid peroxidase antibody

Clinical features

No. (%) with autoantibodies (17 patients)

No. (%) without autoantibodies (77 patients)


Mean age +/- SD, yr

26.47 +/-11.52

29.16 +/- 16.18

Gender

Male

5 (10.4)

43 (89.6)

Female*

12 (26.1)

34 (73.9)

Age (year)

=>17

4 (18.2)

18 (81.8)

18–25*

5 (20.8)

19 (79.2)

26–35*

5 (18.5)

22 (81.5)

=<36

3 (14.3)

18 (85.7)

Mean onset age +/- SD,yr

19.59 +/- 9.5

23.59 +/-16.36

Mean duration +/- SD,yr

6.88 +/- 9.9

5.62 +/- 6.98

Extent (%)

<20

12 (17)

58 (83)

20–50

5 (25)

15 (75)

>50

0

3 (100)

Type of vitiligo

Generalized

13 (20.6)

50 (79.4)

Non-generalized

4 (12.9)

27 (87.1)


*Difference significant compared with the control group (pv < 0.05)

Daneshpazhooh et al. BMC Dermatology 2006 6:3   doi:10.1186/1471-5945-6-3

Open Data